Search - tctmd.com

Displaying 341 - 360 of 568

Sort: Relevancy | Date

Presentation TCT 2016

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Presenter: George L Adams, John F Angle, Raghu Kolluri

October 31, 2016

Presentation TCT 2016

Liberty 360: A Prospective, Multicenter Registry Examining the Outcomes of Different Atherectomy Devices and No Atherectomy in Patients With Symptomatic Peripheral Arterial Disease

Presenter: George L Adams, John F Angle, Jihad A. Mustapha

October 31, 2016

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr.

October 31, 2016

Presentation TCT 2016

What Are the Right Endpoints for CLI Clinical Trials?

Presenter: George L Adams, John F Angle, Patrick J. Geraghty

October 31, 2016

Presentation TCT 2016

Best Practices for BTK Angioplasty and When to Debulk

Presenter: George L Adams, John F Angle, Koen Deloose

October 31, 2016

Presentation TCT 2016

ACT I Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Klaus D. Mathias

October 31, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

When and How Do I Perform Retrograde Tibial Access?

Presenter: George L Adams, John F Angle, Jihad A. Mustapha

October 31, 2016

Presentation TCT 2016

My Favorite Infrapopliteal CTO Techniques: Case Examples

Presenter: George L Adams, John F Angle, Craig M. Walker

October 31, 2016

Presentation TCT 2016

CTSN Severe MR 2-Year Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Patrick M. McCarthy

October 31, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Presentation TCT 2016

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Presenter: William A. Gray, Stephan Windecker

October 31, 2016

Presentation TCT 2016

A Complex Case Presentation (With Discussion): BTK CTO

Presenter: Peter A. Schneider

October 31, 2016

Presentation TCT 2016

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani

October 31, 2016

Presentation TCT 2016

Case 1: Complex Peripheral Intervention

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Chun-Chi Chen

October 31, 2016

Presentation TCT 2016

Great Debate 2: Atherectomy Is Critical for Success of DCB!

Presenter: Eric J. Dippel

October 31, 2016

Presentation TCT 2016

Great Debate 2: Atherectomy Adds Nothing to DCB Success Except Time and Cost!

Presenter: Koen Deloose

October 31, 2016

Presentation TCT 2016

Complications of Coronary and Peripheral Vascular Intervention

Presenter: Sahil A. Parikh, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Presenter: Tony Das, Koen Deloose, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Routine DCB!

Presenter: Tony Das, Koen Deloose, Subhash Banerjee

October 31, 2016

Advertisement

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Liberty 360: A Prospective, Multicenter Registry Examining the Outcomes of Different Atherectomy Devices and No Atherectomy in Patients With Symptomatic Peripheral Arterial Disease

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

What Are the Right Endpoints for CLI Clinical Trials?

Best Practices for BTK Angioplasty and When to Debulk

ACT I Critique: Pro and Con

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

When and How Do I Perform Retrograde Tibial Access?

My Favorite Infrapopliteal CTO Techniques: Case Examples

CTSN Severe MR 2-Year Critique: Pro and Con

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

A Complex Case Presentation (With Discussion): BTK CTO

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Case 1: Complex Peripheral Intervention

Great Debate 2: Atherectomy Is Critical for Success of DCB!

Great Debate 2: Atherectomy Adds Nothing to DCB Success Except Time and Cost!

Complications of Coronary and Peripheral Vascular Intervention

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

No Metallic Implants Anymore: The Case for Routine DCB!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content